These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 179410)

  • 21. Proceedings: Bone mineral analysis in renal osteodystrophy.
    Diamond LH; Smith R; Pierce L
    AJR Am J Roentgenol; 1976 Jun; 126(6):1291-2. PubMed ID: 179411
    [No Abstract]   [Full Text] [Related]  

  • 22. The clinical use of synthetic 1,25-dihydroxycholecalciferol.
    Evans IM; Boulton-Jones M; Doyle FH; Joplin GF; Lockwood M; Matthews EW; MacIntyre I
    Calcif Tissue Res; 1976 Aug; 21 Suppl():236-41. PubMed ID: 782663
    [No Abstract]   [Full Text] [Related]  

  • 23. Calcifediol (25-hydroxyvitamin D3) in the treatment of uremic bone disease.
    Teitelbaum SL
    Ann Intern Med; 1981 Mar; 94(3):404-5. PubMed ID: 6894359
    [No Abstract]   [Full Text] [Related]  

  • 24. [Advances in nephrology].
    Sicinski A
    Pol Arch Med Wewn; 1977 Jan; 57(1):71-9. PubMed ID: 319435
    [No Abstract]   [Full Text] [Related]  

  • 25. 1,25-dihydroxycholecalciferol in renal osteodystrophy. Epiphysiolysis--anticonvulsant therapy.
    Pierides AM; Ellis HA; Dellagrammatikas H; Scott JE; Norman AW
    Arch Dis Child; 1977 Jun; 52(6):464-72. PubMed ID: 879832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Therapy of renal osteopathy].
    Schulz W
    Dtsch Med Wochenschr; 1978 Dec; 103(51):2025-7. PubMed ID: 365485
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparative effect of 1alpha-hydroxycholecalciferol in children and adults with renal glomerular osteodystrophy.
    Henderson RG; Kanis JA; Ledingham JG; Oliver DO; Russel RG; Smith R; Walton RJ
    Calcif Tissue Res; 1976 Aug; 21 Suppl():221-5. PubMed ID: 782661
    [No Abstract]   [Full Text] [Related]  

  • 28. [Dialysis osteopathy with spontaneous fractures, progressive demineralization and therapy resistance].
    Koall W; Luci V
    Z Gesamte Inn Med; 1983 Sep; 38(18):481-8. PubMed ID: 6359738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 24,25 dihydroxycalciferol: assay in non-anephric patients on chronic haemodialysis and assessment of its possible pathophysiological role in renal osteodystrophy.
    Lambrey G; Nguyen TM; Fournier A; Sebert JL; Kassouf J; de Fremont JF; Marie P; Meunier P; Caillens C; Gueris J; Garabedian M; Balsan S
    Proc Eur Dial Transplant Assoc; 1980; 17():548-56. PubMed ID: 6972530
    [No Abstract]   [Full Text] [Related]  

  • 30. [Renal osteodystrophy in children. Therapy with 1,25-dihydroxy-cholechalciferol (author's transl)].
    Bulla M; Delling G; Benz-Bohm G; Stock GJ; Sánchez de Reutter A; Ziegler R; Lühmann H; Severin M; Kalbitzer E; Manegold C
    Klin Wochenschr; 1980 May; 58(10):511-9. PubMed ID: 7392529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolution of renal osteodystrophy: correlation of bone histomorphometry and serum mineral and immunoreactive parathyroid hormone values before and after treatment with calcium carbonate or 25-hydroxycholecalciferol.
    Bordier PJ; Marie PJ; Arnaud CD
    Kidney Int Suppl; 1975 Jan; (2):102-12. PubMed ID: 1057669
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of renal osteodystrophy with 1,25-dihydroxycholecalciferol.
    Velentzas C; Oreopoulos DG; Pierratos A; Meema HE; Rabinovich S; Meindok H; Husdan H; Murray TM; Ogilvie R; Katirtzoglou A
    Can Med Assoc J; 1981 Mar; 124(5):577-83. PubMed ID: 6894103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 1,25 dihydroxyvitamin D3 and osteomalacia: some unanswered questions.
    Velentzas C; Oreopoulos DG
    Int J Artif Organs; 1980 Nov; 3(6):313-5. PubMed ID: 6893977
    [No Abstract]   [Full Text] [Related]  

  • 34. 1alpha-hydroxycholecalciferol and 25-hydroxycholecalciferol in renal bone disease.
    Fournier AE; Bordier PJ; Gueris J; Chanard J; Marie P; Ferriere C; Osario M; Bedrossian J; De Luca HF
    Calcif Tissue Res; 1976 Aug; 21 Suppl():226-35. PubMed ID: 782662
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of 1,25(OH)2D3 and 24,25(OH)2D3 in the long-term treatment of renal osteodystrophy.
    Muirhead N; Catto GR; Edward N; Fraser RA; O'Riordan JL; Papapoulos SE; Adami S
    Proc Eur Dial Transplant Assoc; 1980; 17():543-7. PubMed ID: 6972529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of photon absorptiometry in the diagnosis of renal osteodystrophy.
    Griffiths HJ; Zimmerman RE; Bailey G; Snider R
    Radiology; 1973 Nov; 109(2):277-81. PubMed ID: 4582537
    [No Abstract]   [Full Text] [Related]  

  • 37. 1,25-dihydroxycholecalciferol in patients with chronic renal failure.
    Henderson RG; Ledingham JG; Norman AW; Oliver DO; Preston C; Russell RG; Small DG; Smith R; Warner GT; Woods CG
    Proc Eur Dial Transplant Assoc; 1973; 10(0):202-9. PubMed ID: 4802654
    [No Abstract]   [Full Text] [Related]  

  • 38. [Use of 5,6-trans-25-OH-cholecalciferol in patients needing dialysis with florid renal osteopathy: therapeutic management and treatment results].
    Cremer W; Graben N; Merguet P
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1307-10. PubMed ID: 611841
    [No Abstract]   [Full Text] [Related]  

  • 39. Proceedings: Some long-term effects of 1,25 dihydroxycholecalciferol (1,25(OH)2D3) in man.
    Henderson RG; Ledingham JG; Oliver DO; Small DG; Russell RG; Smith R; Walton RJ; Norman AW
    Clin Sci Mol Med; 1974 Feb; 46(2):10P. PubMed ID: 4817248
    [No Abstract]   [Full Text] [Related]  

  • 40. The investigation and treatment of renal osteodystrophy.
    Catto GR; MacLeod M; Pelc B; Kodicek E
    Proc Eur Dial Transplant Assoc; 1975; 11():473-80. PubMed ID: 1197272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.